Get started
Author

Stephen A. Ansell

Observed names: S.A. Ansell, Stephen A Ansell, Stephen Ansell
OpenAlex ID: A5110140664
AMD3100 Affects Autograft Lymphocyte Collection and Progression-Free Survival After Autologous Stem Cell Transplantion in Non-Hodgkin Lymphoma
2007 · Shernan G. Holtan, Luis F. Porrata, et al. · Clinical Lymphoma & Myeloma · 59
Associations between elevated pre‐treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma
2017 · Moritz Binder, Megan M. O'Byrne, et al. · American Journal of Hematology · 16
PDF
Brentuximab Vedotin Combined with ABVD or AVD for Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma: Long Term Outcomes
2014 · Joseph M Connors, Stephen Ansell, et al. · Blood · 15
Central nervous system involvement by mantle cell lymphoma
2022 · Nicole McLaughlin, Yucai Wang, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13
Checkpoint Inhibitors for the Treatment of Hodgkin Lymphoma
2016 · Nabila Bennani-Baiti, Gita Thanarajasingam, et al. · Expert Review of Clinical Immunology · 7
QIM19-136: Developing an Ideal CAR-T Cell Therapy Patient Experience Through Human-Centered Design and Innovation
2019 · Allison Matthews, Surbhi Sidana, et al. · Journal of the National Comprehensive Cancer Network · 4
How to select the frontline treatment for a patient with peripheral T-cell lymphoma
2016 · Stephen Ansell · Leukemia & lymphoma/Leukemia and lymphoma · 4
Autologous Stem Cell Transplantation for Multiple Myeloma in Patients over 70 Years: A Matched Comparison with Patients under 65 Years.
2005 · Shaji Kumar, Martha Lacy, et al. · Blood · 4
Risk of Thrombosis in CAR T-Cell Therapy Recipients
2021 · Megan Melody, Sangeetha Gandhi, et al. · Transplantation and Cellular Therapy · 3
Effect of AMD3100 on T Lymphocyte Subpopulations in Apheresis Products of Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Non Hodgkin Lymphoma.
2005 · Shernan G. Holtan, Luis F. Porrata, et al. · Blood · 3
American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma
2025 · Sairah Ahmed, Ambuj Kumar, et al. · Transplantation and Cellular Therapy · 2
Impact of Day-100 Response Post Autologous Stem Cell Transplantation (ASCT) in Waldenström Macroglobulinemia (WM)
2016 · Jonas Paludo, Morie Gertz, et al. · Transplantation and Cellular Therapy · 2
The definition of IgM multiple myeloma
2011 · Steven R. Schuster, S. Vincent Rajkumar, et al. · American Journal of Hematology · 2
PDF
474 Phase 1 study of SEA-TGT, a human, nonfucosylated anti-TIGIT monoclonal antibody with enhanced immune-effector function, in patients with advanced malignancies (SGNTGT-001, trial in progress)
2021 · Diwakar Davar, Vincent Ribrag, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin’s Lymphoma (NHL)
2021 · Arushi Khurana, Matthew Hathcock, et al. · Transplantation and Cellular Therapy · 1
Infusion of Autograft Natural Killer Cells/CD14+hla-DRDIM Myeloid-Derived Suppressor Cells Ratio Predicts Survival in Non-Hodgkin Lymphoma Undergoing Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation (APHSCT)
2017 · Ankit J. Kansagra, David J. Inwards, et al. · Transplantation and Cellular Therapy · 1
Time Interval from Last Chemotherapy to Stem Cell Collection Correlates with Peripheral Blood Absolute Lymphocyte Count at Apheresis and Survival Post-Autologous Stem Cell Transplantation in Non-Hodgkin’s Lymphoma.
2004 · Shernan G. Holtan, Luis F. Porrata, et al. · Blood · 1
Machine learning–driven prognostication of overall survival at 6 months after CAR-T cell therapy
2025 · Jonas Paludo, Jacob Shreve, et al. · Blood
Frontline chemotherapy for CD30+ non-ALCL peripheral T-cell lymphoma a multi-center retrospective analysis
2025 · Asaad Trabolsi, Sunwoo Han, et al. · Blood
PDF
Evolution of expert and healthcare professional treatment recommendations in the management of Mantle Cell Lymphoma
2025 · Amber Williams, Kristen Rosenthal, et al. · Blood
PDF
Correlation between Pre-Apheresis Biomarkers and Development of Severe Cytopenias and Therapy-Related Myeloid Neoplasms in Non-Hodgkin Lymphoma Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy
2025 · Andre De Menezes Silva Corraes, Anmol Baranwal, et al. · Transplantation and Cellular Therapy
Abstract 3487: Molecular clusters and functional drivers of IgM monoclonal gammopathies
2022 · Patrizia Mondello, Jonas Paludo, et al. · Cancer Research
Fundamentals of Immunology for Understanding Immunotherapy
2020 · Stephen Ansell · 62nd ASH Annual Meeting and Exposition
Phase II clinical trials for Waldenstrom’s macroglobulinemia
2015 · Rajshekhar Chakraborty, Stephen A Ansell, et al. · Expert Opinion on Orphan Drugs
CD34+ Cell Dose and Full Donor Chimerism at Day +100 Is Associated with Survival in Patients Who Received Reduced-Intensity Conditioning (RIC) With Fludarabine/Melphalan Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies
2009 · S.G. Holtan, W.J. Hogan, et al. · Transplantation and Cellular Therapy
PDF
Works count: 26
Citation count: 138
H-index: 5
I10-index: 4
Year
Topic
Type